1
|
Sotomayor CG, González C, Soto M, Moreno-Bertero N, Opazo C, Ramos B, Espinoza G, Sanhueza Á, Cárdenas G, Yévenes S, Díaz-Jara J, de Grazia J, Manterola M, Castro D, Gajardo AAIJ, Rodrigo R. Ionizing Radiation-Induced Oxidative Stress in Computed Tomography-Effect of Vitamin C on Prevention of DNA Damage: PREVIR-C Randomized Controlled Trial Study Protocol. J Clin Med 2024; 13:3866. [PMID: 38999430 PMCID: PMC11242585 DOI: 10.3390/jcm13133866] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/07/2024] [Revised: 06/14/2024] [Accepted: 06/18/2024] [Indexed: 07/14/2024] Open
Abstract
Exposure to ionizing radiation (IR) is inevitable in various X-ray imaging examinations, with computed tomography (CT) being a major contributor to increased human radiation exposure. Ionizing radiation may cause structural damage to macromolecules, particularly DNA, mostly through an indirect pathway in diagnostic imaging. The indirect pathway primarily involves the generation of reactive oxygen species (ROS) due to water radiolysis induced by IR, leading to DNA damage, including double-strand breaks (DSB), which are highly cytotoxic. Antioxidants, substances that prevent oxidative damage, are proposed as potential radioprotective agents. This Study Protocol article presents the rationale for selecting vitamin C as a preventive measure against CT-associated IR-induced DNA damage, to be investigated in a randomized placebo-controlled trial, with a full in vivo design, using an oral easy-to-use schedule administration in the outpatient setting, for the single CT examination with the highest total global IR dose burden (contrast-enhanced abdomen and pelvis CT). The study also aims to explore the mediating role of oxidative stress, and it has been written in adherence to the Standard Protocol Items recommendations.
Collapse
Affiliation(s)
- Camilo G Sotomayor
- Radiology Department, University of Chile Clinical Hospital, University of Chile, Santiago 8380420, Chile
- Anatomy and Developmental Biology Program, Institute of Biomedical Sciences, Faculty of Medicine, University of Chile, Santiago 8380453, Chile
| | - Camila González
- Faculty of Medicine, University of Santiago Chile, Santiago 9170022, Chile
| | - Miki Soto
- School of Medicine, Faculty of Medicine, University of Chile, Santiago 8380453, Chile
| | | | - Claudina Opazo
- School of Medicine, Faculty of Medicine, University of Chile, Santiago 8380453, Chile
| | - Baltasar Ramos
- School of Medicine, Faculty of Medicine, University of Chile, Santiago 8380453, Chile
| | - Gonzalo Espinoza
- Radiology Department, University of Chile Clinical Hospital, University of Chile, Santiago 8380420, Chile
| | - Álvaro Sanhueza
- Radiology Department, University of Chile Clinical Hospital, University of Chile, Santiago 8380420, Chile
| | - Gonzalo Cárdenas
- Radiology Department, University of Chile Clinical Hospital, University of Chile, Santiago 8380420, Chile
| | - Sebastián Yévenes
- Radiology Department, University of Chile Clinical Hospital, University of Chile, Santiago 8380420, Chile
| | - Jorge Díaz-Jara
- Radiology Department, University of Chile Clinical Hospital, University of Chile, Santiago 8380420, Chile
| | - José de Grazia
- Radiology Department, University of Chile Clinical Hospital, University of Chile, Santiago 8380420, Chile
| | - Marcia Manterola
- Human Genetics Program, Institute of Biomedical Sciences, Faculty of Medicine, University of Chile, Santiago 8380453, Chile
| | - Daniel Castro
- Radiology Department, University of Chile Clinical Hospital, University of Chile, Santiago 8380420, Chile
| | - Abraham A I J Gajardo
- Intensive Care Unit, Medicine Department, University of Chile Clinical Hospital, University of Chile, Santiago 8380420, Chile
- Program of Pathophysiology, Institute of Biomedical Sciences, Faculty of Medicine, University of Chile, 8380453 Santiago, Chile
| | - Ramón Rodrigo
- Molecular and Clinical Pharmacology Program, Institute of Biomedical Sciences, Faculty of Medicine, University of Chile, Santiago 8380000, Chile
| |
Collapse
|
2
|
Schüle S, Hackenbroch C, Beer M, Muhtadi R, Hermann C, Stewart S, Schwanke D, Ostheim P, Port M, Scherthan H, Abend M. Ex-vivo dose response characterization of the recently identified EDA2R gene after low level radiation exposures and comparison with FDXR gene expression and the γH2AX focus assay. Int J Radiat Biol 2023; 99:1584-1594. [PMID: 36988552 DOI: 10.1080/09553002.2023.2194402] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/02/2022] [Accepted: 03/09/2023] [Indexed: 03/30/2023]
Abstract
OBJECTIVE Recently, promising radiation-induced EDA2R gene expression (GE) changes after low level radiation could be shown. Stimulated by that, in this study, we intended to independently validate these findings and to further characterize dose-response relationships in comparison to FDXR and the γH2AX-DNA double-strand break (DSB) focus assay, since both assays are already widely used for biodosimetry purposes. MATERIALS AND METHODS Peripheral blood samples from six healthy human donors were irradiated ex vivo (dose: ranging from 2.6 to 49.7 mGy). Subsequently, the fold-differences relative to the sham irradiated reference group were calculated. Radiation-induced changes in GE of FDXR and EDA2R were examined using the quantitative real-time polymerase-chain-reaction (qRT-PCR). DSB foci were quantified in 100 γH2AX + 53BP1 immunostained cells employing fluorescence microscopy. Examinations were performed at single time points enabling sufficient detection of both endpoints. RESULTS A significant increase in EDA2R GE relative to the unexposed control was observed in the range of 2.6 mGy (1.6-fold, p = .045) to 5.4 mGy (2.2-fold, p = .0002), whereas the copy numbers increased linearly up to 13.1-fold at 49.7 mGy. On the contrary, FDXR upregulation (2.2-fold) became significant after a 22.6 mGy exposure (p ≤ .02) and increased linearly up to 4-fold at 49.7 mGy. A significant increase in radiation-induced foci (relative to unexposed, RIF-fd) was observed after 11.3 mGy (RIF-fd: 1.5 ± 0.5, p ≤ .03), while the foci increased linearly up to 3-fold at 49.7 mGy. From this, the FDXR and RIF-fd slopes have shown comparability, while the EDA2R slope was five times higher. Nevertheless, the coefficient of variation (CV) of EDA2R was about 30% higher than for RIF-fd. CONCLUSION Higher radiation-induced EDA2R GE changes and a lower radiation detection level compared to RIF-fd and FDXR GE changes examined under optimal conditions ex vivo on human samples appear promising. Yet, our results represent just the beginning of further studies to be conducted in animal models for further time- and dose-dependent evaluation and additional examinations on radiologically examined patients to evaluate the impact of confounder, such as age, sex, social behavior, or diseases.
Collapse
Affiliation(s)
- Simone Schüle
- Bundeswehr Institute of Radiobiology, Affiliated to the University of Ulm, Munich, Germany
| | - Carsten Hackenbroch
- Department of Diagnostic and Interventional Radiology and Neuroradiology, German Armed Force Hospital of Ulm, Ulm, Germany
- Department of Radiology, University Hospital of Ulm, Ulm, Germany
| | - Meinrad Beer
- Department of Radiology, University Hospital of Ulm, Ulm, Germany
| | - Razan Muhtadi
- Bundeswehr Institute of Radiobiology, Affiliated to the University of Ulm, Munich, Germany
| | - Cornelius Hermann
- Bundeswehr Institute of Radiobiology, Affiliated to the University of Ulm, Munich, Germany
| | - Samantha Stewart
- Bundeswehr Institute of Radiobiology, Affiliated to the University of Ulm, Munich, Germany
| | - Daniel Schwanke
- Bundeswehr Institute of Radiobiology, Affiliated to the University of Ulm, Munich, Germany
| | - Patrick Ostheim
- Bundeswehr Institute of Radiobiology, Affiliated to the University of Ulm, Munich, Germany
| | - Matthias Port
- Bundeswehr Institute of Radiobiology, Affiliated to the University of Ulm, Munich, Germany
| | - Harry Scherthan
- Bundeswehr Institute of Radiobiology, Affiliated to the University of Ulm, Munich, Germany
| | - Michael Abend
- Bundeswehr Institute of Radiobiology, Affiliated to the University of Ulm, Munich, Germany
| |
Collapse
|
3
|
Sitnikov DS, Ilina IV, Revkova VA, Rodionov SA, Gurova SA, Shatalova RO, Kovalev AV, Ovchinnikov AV, Chefonov OV, Konoplyannikov MA, Kalsin VA, Baklaushev VP. Effects of high intensity non-ionizing terahertz radiation on human skin fibroblasts. BIOMEDICAL OPTICS EXPRESS 2021; 12:7122-7138. [PMID: 34858704 PMCID: PMC8606137 DOI: 10.1364/boe.440460] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/13/2021] [Revised: 10/06/2021] [Accepted: 10/19/2021] [Indexed: 05/08/2023]
Abstract
For the first time, the data have been obtained on the effects of high-intensity terahertz (THz) radiation (with the intensity of 30 GW/cm2, electric field strength of 3.5 MV/cm) on human skin fibroblasts. A quantitative estimation of the number of histone Н2АХ foci of phosphorylation was performed. The number of foci per cell was studied depending on the irradiation time, as well as on the THz pulse energy. The performed studies have shown that the appearance of the foci is not related to either the oxidative stress (the cells preserve their morphology, cytoskeleton structure, and the reactive oxygen species content does not exceed the control values), or the thermal effect of THz radiation. The prolonged irradiation of fibroblasts also did not result in a decrease of their proliferative index.
Collapse
Affiliation(s)
- Dmitry S. Sitnikov
- Joint Institute for High Temperatures of the Russian Academy of Sciences, Moscow, Russia
| | - Inna V. Ilina
- Joint Institute for High Temperatures of the Russian Academy of Sciences, Moscow, Russia
| | - Veronika A. Revkova
- Federal Research and Clinical Center of Specialized Medical Care and Medical Technologies FMBA of Russia, Moscow, Russia
| | - Sergey A. Rodionov
- N. N. Priorov National Medical Research Center of Traumatology and Orthopedics, Moscow, Russia
| | - Svetlana A. Gurova
- National Research nuclear University MEPhI Obninsk Institute for Nuclear Power Engineering, Obninsk, Russia
| | - Rimma O. Shatalova
- National Research nuclear University MEPhI Obninsk Institute for Nuclear Power Engineering, Obninsk, Russia
| | - Alexey V. Kovalev
- N. N. Priorov National Medical Research Center of Traumatology and Orthopedics, Moscow, Russia
| | - Andrey V. Ovchinnikov
- Joint Institute for High Temperatures of the Russian Academy of Sciences, Moscow, Russia
| | - Oleg V. Chefonov
- Joint Institute for High Temperatures of the Russian Academy of Sciences, Moscow, Russia
| | - Mikhail A. Konoplyannikov
- Federal Research and Clinical Center of Specialized Medical Care and Medical Technologies FMBA of Russia, Moscow, Russia
- Institute for Regenerative Medicine, Sechenov First Moscow State Medical University, Moscow, Russia
| | - Vladimir A. Kalsin
- Federal Research and Clinical Center of Specialized Medical Care and Medical Technologies FMBA of Russia, Moscow, Russia
| | - Vladimir P. Baklaushev
- Federal Research and Clinical Center of Specialized Medical Care and Medical Technologies FMBA of Russia, Moscow, Russia
| |
Collapse
|